🔎 Trials Near Me

Home › Leucemia mieloide acuta › Tennessee › Memphis

Studi clinici su Leucemia mieloide acuta a Memphis, TN

15 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Memphis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi di distanza
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

In reclutamentoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi di distanza
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

In reclutamentoFase 1
  • Saint Jude Children's Research Hospital, Memphis
Fino a 21 anni · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07012044

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi di distanza
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi di distanza
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05554406

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

In reclutamentoFase 2
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Tutti i sessi · Aggiornato il 17 set 2026 · NCT05955261

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

In reclutamentoFase 1
  • St. Jude Children's Research Hospital, Memphis
Fino a 25 anni · Tutti i sessi · Aggiornato il 15 set 2026 · NCT06810583

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

In reclutamentoFase 3
  • Baptist Clinical Research Institute, Memphis
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07007312

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

In reclutamentoFase 1
  • Baptist Health Care Corporation, Memphis
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT06399640

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

In reclutamentoFase 1
  • St. Jude Children's Research Hospital, Memphis
Età da 1 a 30 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

In reclutamentoStudio osservazionale
  • St. Jude Childrens Research Hospital, Memphis
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

In reclutamentoFase 1
  • St. Jude Children's Research Hospital, Memphis
Fino a 21 anni · Tutti i sessi · Aggiornato il 22 apr 2026 · NCT05101551

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

In reclutamentoFase 1
  • St. Jude Children's Research Hospital, Memphis
Fino a 21 anni · Tutti i sessi · Aggiornato il 23 gen 2026 · NCT06326463

Studi su Leucemia mieloide acuta in altre città

Altri studi a Memphis

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.